{"id":"2ee93260-2edb-4f62-94c5-4aa1b8fdba68","title":"Revised HSG Cardiovascular Disease Risk Calculator","description":"Introduction:\nThis calculator computes the 10-year Coronary Artery Disease (CAD) risk based on the recalibrated Singapore-modified Framingham Risk Score (SG-FRS-2023) for the general population. In addition, it reminds users to adopt target HbA1c based on individual patient’s context and generates target levels for LDL cholesterol and BP for patients at various levels of cardiovascular risk.\n \nDisclaimer: \nThis calculator, as part of HSG Care Protocols resource, only serve as a guide and should not be used as a replacement for clinical judgment by the relevant professionals or as a substitute for personalised medical advice. \n\nPlease evaluate its appropriateness and relevance, as well as independently verify the contents before relying on the HSG Care Protocols and its resources.\n\nReferences: \nHyperlipidaemia ACE Clinical Guidance 2023\nHypertension ACE Clinical Guidance 2023\n\nLast updated: March 2024","fields":[{"id":"R1","type":"RADIO","title":"1. Please select patient's GENDER","description":"","options":[{"label":"Male","value":0},{"label":"Female","value":1}]},{"id":"DL2","type":"DROPDOWN","title":"2. Please select patient's AGE (years)","description":"","options":[{"label":"a) 20-34","value":0},{"label":"b) 35-39","value":1},{"label":"c) 40-44","value":2},{"label":"d) 45-49","value":3},{"label":"e) 50-54","value":4},{"label":"f) 55-59","value":5},{"label":"g) 60-64","value":6},{"label":"h) 65-69","value":7},{"label":"i) 70-74","value":8},{"label":"j) 75-79","value":9},{"label":"k) ≥ 80","value":10}]},{"id":"R3","type":"RADIO","title":"3. Please select patient's ETHNICITY:","description":"Note: As there is insufficient data for other ethnic minorities, the 10-Year  Coronary Artery Disease Risk Score for the lowest risk group (i.e. Chinese) applies for these individuals.","options":[{"label":"Chinese","value":0},{"label":"Malay","value":1},{"label":"Indian","value":2},{"label":"Others","value":3}]},{"id":"R4","type":"RADIO","title":"4. Is patient a cigarette SMOKER?","description":"","options":[{"label":"No","value":0},{"label":"Yes","value":1}]},{"id":"DL10","type":"DROPDOWN","title":"5. Please select patient's HDL Cholesterol range","description":"mmol/L (mg/dl)","options":[{"label":"a) ≥ 1.6 (60)","value":0},{"label":"b) 1.3-1.5 (50-59)","value":1},{"label":"c) 1.0-1.2 (40-49)","value":2},{"label":"d) < 1.0 (40)","value":3}]},{"id":"DL9","type":"DROPDOWN","title":"6. Please select patient's Total Cholesterol (TC) range","description":"mmol/L (mg/dl)","options":[{"label":"a) < 4.1 (160)","value":0},{"label":"b) 4.1-5.1 (160-199)","value":1},{"label":"c) 5.2-6.1 (200-239)","value":2},{"label":"d) 6.2-7.2 (240-279)","value":3},{"label":"e) ≥ 7.3 (280)","value":4}]},{"id":"DL11","type":"DROPDOWN","title":"7. Please select patient's SYSTOLIC BP range","description":"mmHg","options":[{"label":"a) < 120","value":0},{"label":"b) 120-129","value":1},{"label":"c) 130-139","value":2},{"label":"d) 140-159","value":3},{"label":"e) ≥ 160","value":4}]},{"id":"R13","type":"RADIO","title":"8. Is the patient on antihypertensives?","description":"","options":[{"label":"No","value":0},{"label":"Yes","value":1}]},{"id":"R5","type":"RADIO","title":"9. Does the patient have a history of Acute Coronary Syndrome (ACS)?","description":"","options":[{"label":"No","value":0},{"label":"Yes","value":1}]},{"id":"R14","type":"RADIO","title":"10. Does the patient have a history of atherosclerotic cardiovascular disease (ASCVD), other than ACS?","description":"E.g., History of other stable ischaemic heart disease, ischaemic stroke, transient ischaemic attack, peripheral artery disease, abdominal aortic aneurysm, post coronary artery bypass graft, post percutaneous coronary intervention.","options":[{"label":"No","value":0},{"label":"Yes","value":1}]},{"id":"R6","type":"RADIO","title":"11. Does patient have familial hypercholesterolaemia (FH)?","description":"If LDL-cholesterol >4.9 mmol/L, consider work-up for FH","options":[{"label":"No","value":0},{"label":"Yes AND with additional cardiovascular risk factor(s) (e.g., subclinical atherosclerosis if investigated)","value":1},{"label":"Yes AND with no additional cardiovascular risk factors","value":2}]},{"id":"R8","type":"RADIO","title":"12. Does the patient have chronic kidney disease?","description":"i.e., eGFR < 60ml/min/1.73㎡ OR uACR ≥ 3mg/mmol (30mg/g) OR uPCR >15mg/mmol (150mg/g)?","options":[{"label":"No","value":0},{"label":"Yes","value":1}]},{"id":"R7","type":"RADIO","title":"13. Does patient have diabetes mellitus (DM)?","description":"","options":[{"label":"No","value":0},{"label":"Yes, with any of these specific risk factors: (1) Chronic kidney disease; (2) Multiple microvascular complications; (3) Diabetes disease duration ≥10 years; (4) Glycaemic level persistently above target despite optimal treatment.","value":1},{"label":"Yes, but without the specific risk factors mentioned above","value":2}]}],"constants":[],"operations":[{"id":"O5","type":"ARITHMETIC","title":"Calculate age risk score  ","expression":"ifelse(R1==\"Male\",\nifelse(DL2==\"a) 20-34\",-9 ,\nifelse(DL2==\"b) 35-39\",-4, \nifelse(DL2==\"c) 40-44\",0,\nifelse(DL2==\"d) 45-49\",3,\nifelse(DL2==\"e) 50-54\",6,\nifelse(DL2==\"f) 55-59\",8,\nifelse(DL2==\"g) 60-64\",10,\nifelse(DL2==\"h) 65-69\",11,\nifelse(DL2==\"i) 70-74\",12,13)\n)\n)\n)\n)\n)\n)\n)\n)\n,ifelse(DL2==\"a) 20-34\",-7 ,\nifelse(DL2==\"b) 35-39\",-3, \nifelse(DL2==\"c) 40-44\",0,\nifelse(DL2==\"d) 45-49\",3,\nifelse(DL2==\"e) 50-54\",6,\nifelse(DL2==\"f) 55-59\",8,\nifelse(DL2==\"g) 60-64\",10,\nifelse(DL2==\"h) 65-69\",12,\nifelse(DL2==\"i) 70-74\",14,16)\n)\n)\n)\n)\n)\n)\n)\n))","show":false},{"id":"O4","type":"ARITHMETIC","title":"Significant medical conditions check","expression":"ifelse((R5 == \"Yes\"), 99, \nifelse((R6 == \"Yes AND with additional cardiovascular risk factor(s) (e.g., subclinical atherosclerosis if investigated)\") or (R7==\"Yes, with any of these specific risk factors: (1) Chronic kidney disease; (2) Multiple microvascular complications; (3) Diabetes disease duration ≥10 years; (4) Glycaemic level persistently above target despite optimal treatment.\") or (R6 == \"Yes AND with no additional cardiovascular risk factors\" and (O5>=0 or DL11==\"d) 140-159\" or DL11==\"e) ≥ 160\" or R4==\"Yes\" or R13==\"Yes\" or R7!=\"No\")) or (R7==\"Yes, but without the specific risk factors mentioned above\" and R8==\"Yes\"), 88,\n\nifelse(R14==\"Yes\",87,\n\nifelse(R6 == \"Yes AND with no additional cardiovascular risk factors\" ,77,\n\nifelse(R7==\"Yes, but without the specific risk factors mentioned above\" or R8==\"Yes\",66,\n\n0)))))","show":false},{"id":"O6","type":"ARITHMETIC","title":"Calculate Total Cholesterol risk score","expression":"ifelse(R1==\"Male\",\nifelse(DL9==\"a) < 4.1 (160)\",0 ,\nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (O5<=-4),4, \nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (-4<O5<=3),3,\nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (3<O5<=8),2,\nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (8<O5<=11),1,\nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (11<O5),0,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (O5<=-4),7,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (-4<O5<=3),5,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (3<O5<=8),3,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (8<O5<=11),1,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (11<O5),0,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (O5<=-4),9,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (-4<O5<=3),6,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (3<O5<=8),4,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (8<O5<=11),2,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (11<O5),1,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (O5<=-4),11,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (-4<O5<=3),8,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (3<O5<=8),5,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (8<O5<=11),3,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (11<O5),1,0)\n)))))\n)))))\n)\n)\n)\n)\n)\n)\n)\n)\n)\n)\n,\nifelse(DL9==\"a) < 4.1 (160)\",0 ,\nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (O5<=-4),4, \nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (-4<O5<=3),3,\nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (3<O5<=8),2,\nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (8<O5<=12),1,\nifelse(DL9==\"b) 4.1-5.1 (160-199)\" and (12<O5),1,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (O5<=-4),8,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (-4<O5<=3),6,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (3<O5<=8),4,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (8<O5<=12),2,\nifelse(DL9==\"c) 5.2-6.1 (200-239)\" and (12<O5),1,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (O5<=-4),11,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (-4<O5<=3),8,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (3<O5<=8),5,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (8<O5<=12),3,\nifelse(DL9==\"d) 6.2-7.2 (240-279)\" and (12<O5),2,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (O5<=-4),13,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (-4<O5<=3),10,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (3<O5<=8),7,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (8<O5<=12),4,\nifelse(DL9==\"e) ≥ 7.3 (280)\" and (12<O5),2,2)\n)))))\n)))))\n)\n)\n)\n)\n)\n)\n)\n)\n)\n))","show":false},{"id":"O7","type":"ARITHMETIC","title":"Calculate Smoking risk score","expression":"ifelse(R1==\"Male\",\nifelse(R4==\"No\",0 ,\nifelse((O5<=-4),8, \nifelse((-4<O5<=3),5,\nifelse((3<O5<=8),3,\nifelse((8<O5<=11),1,\nifelse((11<O5),1,0)\n)\n)\n)\n)\n)\n,\nifelse(R4==\"No\",0 ,\nifelse((O5<=-4),9, \nifelse((-4<O5<=3),7,\nifelse((3<O5<=8),4,\nifelse((8<O5<=12),2,\nifelse((12<O5),1,0)\n)\n)\n)\n)\n)\n)","show":false},{"id":"O8","type":"ARITHMETIC","title":"Calculate HDL Cholesterol risk score","expression":"ifelse(R1==\"Male\",\nifelse(DL10==\"a) ≥ 1.6 (60)\",-1 ,\nifelse(DL10==\"b) 1.3-1.5 (50-59)\",0, \nifelse(DL10==\"c) 1.0-1.2 (40-49)\",1,\nifelse(DL10==\"d) < 1.0 (40)\",2,0)\n)\n)\n)\n,\nifelse(DL10==\"a) ≥ 1.6 (60)\",-1 ,\nifelse(DL10==\"b) 1.3-1.5 (50-59)\",0, \nifelse(DL10==\"c) 1.0-1.2 (40-49)\",1,\nifelse(DL10==\"d) < 1.0 (40)\",2,0)\n)\n)\n)\n)","show":false},{"id":"O9","type":"ARITHMETIC","title":"Calculate Systolic BP risk score","expression":"ifelse(R1==\"Male\",\nifelse(DL11==\"a) < 120\",0 ,\nifelse(DL11==\"b) 120-129\" and R13==\"No\",0, \nifelse(DL11==\"b) 120-129\" and R13==\"Yes\",1,\nifelse(DL11==\"c) 130-139\" and R13==\"No\",1, \nifelse(DL11==\"c) 130-139\" and R13==\"Yes\",2,\nifelse(DL11==\"d) 140-159\" and R13==\"No\",1, \nifelse(DL11==\"d) 140-159\" and R13==\"Yes\",2,\nifelse(DL11==\"e) ≥ 160\" and R13==\"No\",2,3)\n))))\n)\n)\n)\n,\nifelse(DL11==\"a) < 120\",0 ,\nifelse(DL11==\"b) 120-129\" and R13==\"No\",1, \nifelse(DL11==\"b) 120-129\" and R13==\"Yes\",3,\nifelse(DL11==\"c) 130-139\" and R13==\"No\",2, \nifelse(DL11==\"c) 130-139\" and R13==\"Yes\",4,\nifelse(DL11==\"d) 140-159\" and R13==\"No\",3, \nifelse(DL11==\"d) 140-159\" and R13==\"Yes\",5,\nifelse(DL11==\"e) ≥ 160\" and R13==\"No\",4,6)\n))))\n)\n)\n)\n)","show":false},{"id":"O10","type":"ARITHMETIC","title":"Total Points","expression":"O5+O6+O7+O8+O9","show":false},{"id":"O11","type":"ARITHMETIC","title":"Risk Score (%) based on Recalibrated SG-ATP III","expression":"ifelse(R1==\"Male\",\n ifelse(R3==\"Chinese\" or R3==\"Others\",\n  ifelse(-10<=O10<=7,1,\n  ifelse(7<O10<=9,2,\n  ifelse(O10==10,3,\n  ifelse(O10==11,3,\n  ifelse(O10==12,4,\n  ifelse(O10==13,5,\n  ifelse(O10==14,7,\n  ifelse(O10==15,9,\n  ifelse(O10==16,11,\n  ifelse(O10==17,14,\n  ifelse(O10==18,18,\n  ifelse(O10==19,23,\n  28)))))))))))),\n\nifelse(R3==\"Malay\",\n  ifelse(-10<=O10<=5,1,\n  ifelse(5<O10<=7,2,\n  ifelse(O10==8,3,\n  ifelse(O10==9,3,\n  ifelse(O10==10,4,\n  ifelse(O10==11,5,\n  ifelse(O10==12,7,\n  ifelse(O10==13,9,\n  ifelse(O10==14,11,\n  ifelse(O10==15,14,\n  ifelse(O10==16,18,\n  ifelse(O10==17,22,\n  ifelse(O10==18,28,\n  ifelse(O10==19,34,\n  42)))))))))))))),\n  \nifelse(R3==\"Indian\",\n  ifelse(-10<=O10<=4,1,\n  ifelse(4<O10<=6,2,\n  ifelse(O10==7,3,\n  ifelse(O10==8,4,\n  ifelse(O10==9,5,\n  ifelse(O10==10,6,\n  ifelse(O10==11,7,\n  ifelse(O10==12,10,\n  ifelse(O10==13,12,\n  ifelse(O10==14,15,\n  ifelse(O10==15,19,\n  ifelse(O10==16,24,\n  ifelse(O10==17,30,\n  ifelse(O10==18,37,\n  ifelse(O10==19,45,\n  54)))))))))))))))\n\n ,0)))\n\n\n,\nifelse(R3==\"Chinese\" or R3==\"Others\",\n  ifelse(-8<=O10<=16,1,\n  ifelse(O10==17,2,\n  ifelse(O10==18,2,\n  ifelse(O10==19,3,\n  ifelse(O10==20,4,\n  ifelse(O10==21,5,\n  ifelse(O10==22,7,\n  ifelse(O10==23,8,\n  ifelse(O10==24,11,\n  ifelse(O10==25,14,\n  ifelse(O10==26,18,\n  22))))))))))),\n\nifelse(R3==\"Malay\",\n  ifelse(-8<=O10<=14,1,\n  ifelse(14<O10<=16,2,\n  ifelse(O10==17,3,\n  ifelse(O10==18,4,\n  ifelse(O10==19,5,\n  ifelse(O10==20,7,\n  ifelse(O10==21,9,\n  ifelse(O10==22,11,\n  ifelse(O10==23,14,\n  ifelse(O10==24,18,\n  ifelse(O10==25,23,\n  ifelse(O10==26,29,\n  36)))))))))))),\n  \nifelse(R3==\"Indian\",\n  ifelse(-8<=O10<=12,1,\n  ifelse(12<O10<=14,2,\n  ifelse(14<O10<=16,3,\n  ifelse(O10==17,4,\n  ifelse(O10==18,6,\n  ifelse(O10==19,7,\n  ifelse(O10==20,10,\n  ifelse(O10==21,12,\n  ifelse(O10==22,16,\n  ifelse(O10==23,20,\n  ifelse(O10==24,25,\n  ifelse(O10==25,31,\n  ifelse(O10==26,39,\n  47)))))))))))))\n\n ,0)))\n)","show":false},{"id":"O3","type":"ARITHMETIC","title":"Calculated 10-Yr Coronary Artery Disease Risk","expression":"ifelse(O4==99,  ifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High risk (Secondary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+paragraph(\"Target LDL cholesterol:\") +paragraph(\"Aim for LDL-C <1.4mmol/L (<55mg/dL).\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High risk (Secondary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+paragraph(\"Target LDL cholesterol:\") +paragraph(\"Aim for LDL-C <1.4mmol/L (<55mg/dL).)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") )\n, \n\nifelse(O4==88, ifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Primary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C <1.8 mmol/L (<70mg/dL)\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,\n\nifelse(R6 == \"Yes AND with no additional cardiovascular risk factors\" and (O5==0 and (DL11!=\"d) 140-159\" and DL11!=\"e) ≥ 160\") and R4!=\"Yes\" and R13!=\"Yes\" and R7==\"No\"), paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Primary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"If patient is 40 years old: Consider LDL-C < 2.6 mmol/L (100mg/dL)\") + paragraph(\"If patient is 41 years old or older: Consider LDL-C <1.8 mmol/L (<70mg/dL)\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\"),paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Primary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C <1.8 mmol/L (<70mg/dL)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\"))),\n\nifelse(O4==87, ifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Secondary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Aim for LDL-C <1.8 mmol/L (<70 mg/dL), consider lower based on clinical need and tolerability\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Secondary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Aim for LDL-C <1.8 mmol/L (<70 mg/dL), consider lower based on clinical need and tolerability\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ),\n\nifelse(O4==77,ifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Primary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C < 2.6 mmol/L (100mg/dL)\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Primary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C < 2.6 mmol/L (100mg/dL)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ) ,\n\nifelse(O4==66, ifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Primary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Aim for LDL-C < 2.6 mmol/L (100mg/dL), consider lower based on clinical need and tolerability.\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Very High/ High risk (Primary Prevention)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Aim for LDL-C < 2.6 mmol/L (100mg/dL), consider lower based on clinical need and tolerability.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") )\n,\n\nifelse(DL2==\"k) ≥ 80\", \nparagraph(\"As patient is over 80 years old, we are not able to provide a risk assessment as the Framingham risk score has only been validated for individuals between 20 to 79 years old.\"),\n\n\nifelse(O11<5, ifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Yr Coronary Artery Disease Risk:\")+ paragraph(\"Low risk (<5%)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider ideal LDL-C <3.4 mmol/L (<130 mg/dL).\")+ paragraph(\"Focus on lifestyle intervention.\") + paragraph (\"Consider risk-benefit discussion for a statin if LDL-C persistently >4.1 mmol/L (>160 mg/dL)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Yr Coronary Artery Disease Risk:\")+ paragraph(\"Low risk (<5%)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider ideal LDL-C <3.4 mmol/L (<130 mg/dL).\")+ paragraph(\"Focus on lifestyle intervention.\") + paragraph (\"Consider risk-benefit discussion for a statin if LDL-C persistently >4.1 mmol/L (>160 mg/dL)\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") )\n\n,\n\nifelse(5<=O11<10,ifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Borderline risk (5 to <10%)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C < 3.4 mmol/L (130 mg/dL)\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"Borderline risk (5 to <10%)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C < 3.4 mmol/L (130 mg/dL)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ) ,\n\nifelse(10<=O11<=20, ifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Yr Coronary Artery Disease Risk:\")+ paragraph(\"Intermediate risk (10 - 20%)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C <2.6 mmol/L (<100mg/dL)\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Yr Coronary Artery Disease Risk:\")+ paragraph(\"Intermediate risk (10 - 20%)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C <2.6 mmol/L (<100mg/dL)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") )\n,\n\nifelse(DL2==\"j) 75-79\",paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"High risk (>20%)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C < 1.8 mmol/L (< 70mg/dL)\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"While older age (>75 years) is not a contraindication for statin use, factors to be considered include potential benefits, risk of side effects (noting that renal or hepatic impairment and potential for drug interactions may be more likely), patient preference, and functional status.\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ,paragraph(\"------------------------------------------------------------\")+paragraph(\"Estimated 10-Year Coronary Artery Disease Risk:\")+ paragraph(\"High risk (>20%)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Target LDL cholesterol:\")+ paragraph(\"Consider LDL-C < 1.8 mmol/L (< 70mg/dL)\")+ paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Lipid Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/lipid-disorders\") + \" for more details\") ))))))))))","show":true},{"id":"O12","type":"ARITHMETIC","title":"Tgt. BP calculation ","expression":"ifelse(DL2==\"k) ≥ 80\",0,\n ifelse(R8==\"Yes\" or R5==\"Yes\" or R7!=\"No\" or R6!=\"No\" or O11>20 or R5==\"Yes\" or R14==\"Yes\",1,4\n))","show":false},{"id":"O13","type":"ARITHMETIC","title":"Target Blood Pressure","expression":"ifelse(O12==0, \nparagraph(\"------------------------------------------------------------\")+paragraph(\"Target Blood Pressure:\")+ paragraph(\"Consider less stringent BP targets (e.g. <150/90 mmHg)\")+ paragraph(\"------------------------------------------------------------\")+paragraph(\"Refer to the \"+ link(\"Hypertension Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/hypertension\") + \" for more details\"),\n\nifelse(O12==1, \nparagraph(\"------------------------------------------------------------\")+paragraph(\"Target Blood Pressure:\")+ paragraph(\"<130/80 mmHg\")+ paragraph(\"------------------------------------------------------------\")+paragraph(\"Refer to the \"+ link(\"Hypertension Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/hypertension\") + \" for more details\"),\n\nparagraph(\"------------------------------------------------------------\")+paragraph(\"Target Blood Pressure:\")+ paragraph(\"<140/90 mmHg\")+paragraph(\"Consider going lower (e.g. <130/80 mmHg) as tolerated, especially if the patient has hypertension-mediated organ damage (HMOD).\")+paragraph(\"------------------------------------------------------------\")+ paragraph(\"Refer to the \"+ link(\"Hypertension Care Protocol\",\"https://www.primarycarepages.sg/healthier-sg/care-protocols/chronic-care-protocols/hypertension\") + \" for more details\")))","show":true},{"id":"O15","type":"ARITHMETIC","title":"Target HbA1c","expression":"ifelse(R7==\"No\", paragraph(\"No target HbA1c recommendation, as patient does not have diabetes mellitus.\"),\nparagraph(\"For most patients, a target HbA1c of ≤ 7.0% provides a reasonable balance between a reduction in risk of microvascular complications and risk of hypoglycaemia.\")+ paragraph(\"------------------------------------------------------------\") + paragraph(\"Examples of when a more stringent HbA1c target (e.g., ≤ 6.5%) may be appropriate: Younger patients, patients with short duration of disease, long life expectancy or early-stage microvascular complications (particularly retinopathy and nephropathy).\") + paragraph(\"------------------------------------------------------------\")+ paragraph(\"Examples of when a less stringent HbA1c target (e.g., ≤ 8.0%) may be appropriate: Older patients, especially if frail, patients with long duration of disease, short life expectancy, advanced microvascular or macrovascular complications.\") )","show":true}],"displays":[],"isActive":true}